Cat.#: ACPP-1637
Despition | NRN1 Human Recombinant, His |
SIZE | 2 µg |
Purity | Purity as determined by densitometric image analysis is > 95%. |
Form | Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1816 | Human TRH Protein (AC1816) | 2 µg | inquiry |
ACPP-1085 | Recombinant Human alpha Internexin Protein (AC1085) | 25 µl | inquiry |
ACPP-1606 | Human GAD2 Protein (AC1606) | 50 µg | inquiry |
ACPP-1223 | PAX8 Blocking Peptide (AC1223) | 250 µg | inquiry |
ACPP-1373 | Human Interleukin 6 (Active) Protein (AC1373) | 10 µg | inquiry |
ACPP-1649 | Human EFNA5 Protein (AC1649) | 2 µg | inquiry |
ACPP-1707 | Human RAB5B Protein (AC1707) | 5 µg | inquiry |
ACPP-1298 | Syndecan-1 Blocking Peptide (AC1298) | 250 µg | inquiry |
ACPP-1423 | Human ALDH5A1 Protein (AC1423) | 2 µg | inquiry |
ACPP-1004 | Synthetic Nanodisc Human GPCR GPR20 Protein (AC1004) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.